MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA

被引:97
|
作者
Wang, Yihui [1 ]
Tang, Qingchao [2 ]
Li, Mingqi [1 ]
Jiang, Shixiong [1 ]
Wang, Xishan [2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Ctr Canc, Harbin 150086, Peoples R China
关键词
miR-375; Colorectal cancer; PIK3CA; PI3K; Akt; PI3K-AKT PATHWAY; DOWN-REGULATION; GASTRIC-CANCER; MIR-375; PROTEIN; CELLS; PROGRESSION; EXPRESSION; NEOPLASIA; CARCINOMA;
D O I
10.1016/j.bbrc.2014.01.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is the second most common cause of death from cancer. MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by triggering RNA degradation or interfering with translation. Aberrant miRNA expression is involved in human disease including cancer. Herein, we showed that miR-375 was frequently down-regulated in human colorectal cancer cell lines and tissues when compared to normal human colon tissues. PIK3CA was identified as a potential miR-375 target by bioinformatics. Overexpression of miR-375 in SW480 and HCT15 cells reduced PIIGCA protein expression. Subsequently, using reporter constructs, we showed that the PIK3CA untranslated region (3'-UTR) carries the directly binding site of miR-375. Additionally, miR-375 suppressed CRC cell proliferation and colony formation and led to cell cycle arrest. Furthermore, miR-375 overexpression resulted in inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. SiRNA-mediated silencing of PIK3CA blocked the inhibitory effect of miR-375 on CRC cell growth. Lastly, we found overexpressed miR-375 effectively repressed tumor growth in xenograft animal experiments. Taken together, we propose that overexpression of miR-375 may provide a selective growth inhibition for CRC cells by targeting PI3K/Akt signaling pathway. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [21] THE EXPRESSION OF MICRORNA-375 IN PLASMA AND TISSUE IS MATCHED IN HUMAN COLORECTAL CANCER
    An, Guangyu
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 55 - 55
  • [22] RETRACTED: MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA (Retracted Article)
    Liu, Jia
    Li, Qun
    Li, Rui
    Ren, Peiyou
    Dong, Su
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (01): : 148 - 158
  • [23] Functional analysis of PIK3CA gene mutations in human colorectal cancer
    Ikenoue, T
    Kanai, F
    Hikiba, Y
    Obata, T
    Tanaka, Y
    Imamura, J
    Ohta, M
    Jazag, A
    Guleng, B
    Tateishi, K
    Asaoka, Y
    Matsumura, M
    Kawabe, T
    Omata, M
    [J]. CANCER RESEARCH, 2005, 65 (11) : 4562 - 4567
  • [24] The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
    Eklof, V.
    Wikberg, M. L.
    Edin, S.
    Dahlin, A. M.
    Jonsson, B-A
    Oberg, A.
    Rutegard, J.
    Palmqvist, R.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2153 - 2163
  • [25] Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4358 - 4361
  • [26] Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
    Yujun Hao
    Yardena Samuels
    Qingling Li
    Dawid Krokowski
    Bo-Jhih Guan
    Chao Wang
    Zhicheng Jin
    Bohan Dong
    Bo Cao
    Xiujing Feng
    Min Xiang
    Claire Xu
    Stephen Fink
    Neal J. Meropol
    Yan Xu
    Ronald A. Conlon
    Sanford Markowitz
    Kenneth W. Kinzler
    Victor E. Velculescu
    Henri Brunengraber
    Joseph E. Willis
    Thomas LaFramboise
    Maria Hatzoglou
    Guo-Fang Zhang
    Bert Vogelstein
    Zhenghe Wang
    [J]. Nature Communications, 7
  • [27] PIK3CA mutation in colorectal cancer:: Relationship with genetic and epigenetic alterations
    Nosho, Katsuhiko
    Kawasaki, Takako
    Ohnishi, Mutsuko
    Suemoto, Yuko
    Kirkner, Gregory J.
    Zepf, Dimity
    Yan, Liying
    Longtine, Janina A.
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. NEOPLASIA, 2008, 10 (06): : 534 - 541
  • [28] Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
    Hao, Yujun
    Samuels, Yardena
    Li, Qingling
    Krokowski, Dawid
    Guan, Bo-Jhih
    Wang, Chao
    Jin, Zhicheng
    Dong, Bohan
    Cao, Bo
    Feng, Xiujing
    Xiang, Min
    Xu, Claire
    Fink, Stephen
    Meropol, Neal J.
    Xu, Yan
    Conlon, Ronald A.
    Markowitz, Sanford
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Brunengraber, Henri
    Willis, Joseph E.
    LaFramboise, Thomas
    Hatzoglou, Maria
    Zhang, Guo-Fang
    Vogelstein, Bert
    Wang, Zhenghe
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [29] Clinicopathologic and molecular associations of PIK3CA and PTEN mutation in colorectal cancer
    Day, Fiona Lee
    Desai, Jayesh
    Jorissen, Robert N.
    Gibbs, Peter
    Mouradov, Dmitri
    Li, Shan
    Sieber, Oliver
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] A Small Cog in a Big Wheel: PIK3CA Mutations in Colorectal Cancer
    Stintzing, Sebastian
    Lenz, Heinz-Josef
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (23) : 1775 - 1776